Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
3237933
Reference Type
Journal Article
Title
Paraoxon Down Regulates ATP-binding Cassette Transporter A1 Expression and Decreases Cholesterol Efflux Through Cyclic AMP Signaling Pathway in RAW 264.7 Macrophage-derived Foam Cells
Author(s)
Zhou Shou-Hong; Yang Xu-Hong; Wu Shu-Jin; Chen Geng-Rong; Liu Li-Ying
Year
2010
Is Peer Reviewed?
1
Journal
Shengwu Huaxue yu Shengwu Wuli Jinzhan / Progress in Biochemistry and Biophysics
ISSN:
1000-3282
Volume
37
Issue
2
Page Numbers
190-199
DOI
10.3724/SP.J.1206.2009.00476
Web of Science Id
WOS:000275101900010
Abstract
ATP-binding Cassette Transporter A I (ABCA I) plays a critical role in the reverse cholesterol transport (RCT) Previous studies showed that paraoxon, the active metabolite of organophosphorus insecticide, increased cholesterol retention in macrophages However, its underlying mechanisms remain to be elucidated The effect of paraoxon on ABCA I expression and ABCA I-dependent cholesterol efflux was investigated, and then the role of cyclic adenosine monophospate (cAMP) signaling pathway in the regulation of ABCA I expression and ABCA I-mediated cholesterol efflux was examined by paraoxon, in RAW 264 7 macrophage-derived foam cells Results showed that paraoxon significantly down regulated ABCA I expression and reduced ABCA I-dependent cholesterol efflux and increased the levels of the total, free and esterified cholesterols in a time- and dose-dependent manner Paraoxon also markedly reduced cAMP level and decreased adenylate cyclase (AC) activity and increased cAMP-specific phosphodicsterase (PDE) activity Furthermore, cAMP analogs dibutyryl cyclic adenosine monophosphate (dBcAMP) markedly compensated the down-regulation of ABCAI expression and partly compensated the reduction of ABCAI-mcdiated cholesterol efflux induced by paraoxon. Also, both adenylate cyclase agonist forskolin and phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX) markedly compensated the suppression effect on cAMP level induced by paraoxon In conclusion, the results mentioned above suggest that paraoxon down regulates ABCA I expression and decreases ABCAI-mediated cholesterol efflux through cyclic AMP signaling pathway in RAW 264.7 macrophage-derived foam cells
Keywords
paraoxon; ABCA1; cAMP; atherosclerosis; reverse cholesterol transport
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity